Y-mAbs Therapeutics Inc (NASDAQ:YMAB)

4.41
Delayed Data
As of 4:00pm ET
 +0.17 / +4.01%
Today’s Change
2.94
Today|||52-Week Range
20.48
-72.79%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2016

2017

2018

--
Operating ActivitiesNet Income / Starting Line-17.1M-19.2M-43.3M--
 
 
 
 
Depreciation--0.0029.0K--
 
 
Total Other Cash Flow2.5M546.0K2.1M--
 
 
 
 
Funds From Operations-14.5M-18.6M-41.2M--
 
 
 
 
Funds From/For Other Operating Expenses-3.4M-2.7M47.0K--
 
 
 
 
Net Cash Flow - Operating Activities-11.2M-15.9M-41.2M--
 
 
 
 
 
InvestingCapital Expenditures--0.00-234.0K--
 
 
Net Cash Flow Investing0.000.00-234.0K--
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings0.000.000.00----
Long Term Debt Reduction0.000.000.00----
Net Proceeds Stock Sale19.3M89.8M99.8M--
 
 
 
 
Common Preferred Redeemed-366.0K0.000.00--
 
 
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.000.00----
Other Uses - Financing0.00258.0K1.0M--
 
 
 
Net Cash Flow - Financing19.0M89.6M98.8M--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash---108.0K56.0K--
 
 
 
 
Net Change In Cash7.8M73.7M57.3M--